Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 19Breast Neoplasms 15Prostatic Neoplasms 14Colorectal Neoplasms 14Hematopoietic and Lymphatic System Neoplasm 12Lung Neoplasms 10Ovarian Neoplasms 5Multiple Myeloma 5Hematologic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Malignant Solid Neoplasm 4Hematopoietic and Lymphoid System Neoplasm 4Depression 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Lymphoma 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Anxiety Disorders 3Anatomic Stage I Breast Cancer AJCC v8 3Advanced Malignant Solid Neoplasm 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Cancer, Papillary 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Motor Activity 2Melanoma 2Malignant Female Reproductive System Neoplasm 2Leukemia 2

Interventions

pembrolizumab 155Gemcitabine 139Capecitabine 121Paclitaxel 118Fluorouracil 116Oxaliplatin 110Bevacizumab 104Nivolumab 97Leucovorin 97Docetaxel 92Cisplatin 89Irinotecan 87Carboplatin 84Radiosurgery 83Cyclophosphamide 70Cetuximab 70Magnetic Resonance Spectroscopy 68Trastuzumab 56Specimen Handling 56Biopsy 56Radiotherapy 55Ipilimumab 52Everolimus 48Pemetrexed 46Drug Therapy 45Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 43Doxorubicin 41Fulvestrant 38aldesleukin 37

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Neoplasm Metastasis × Interviews as Topic × Clear all
NCT05455606 2026-01-22

Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment

SWOG Cancer Research Network

Phase NA Active not recruiting
1,284 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04697524 2023-08-15

Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer

University of California, San Francisco

Phase NA Completed
30 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02523378 2020-12-21

Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-Completion

M.D. Anderson Cancer Center

Phase NA Completed
138 enrolled

Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡